Skip to main content
. 2013 Sep;34(9):1682–1689. doi: 10.3174/ajnr.A3342

Fig 3.

Fig 3.

In contrast to controls,30 spectra (A) measured in different pathologies (B–E)33,37 in the spinal cord show a distinct change in the metabolite fingerprint, with high correlation to connatural MR spectroscopy acquisitions in the brain. Spectra measured in the normal-appearing spinal cord of patients with MS33 show an increase of myo-inositol/Cr and Cho/Cr and a decrease in NAA/Cr. The extradural tumor (schwannoma) shown in D does not contain any metabolite observable in healthy neural tissue.33 In contrast, the biopsy-confirmed ependymoma exhibited strongly reduced NAA/Cr, increased Cho/Cr, and strongly increased myo-inositol/Cr, in addition to increased lipid and lactate, compared to controls.33 The spectra measured in a patient after a traumatic injury37 also show a reduction in the NAA/Cr.